Your browser doesn't support javascript.
Efficacy of Pranayama in Preventing COVID-19 in Exposed Healthcare Professionals: A Quasi-Randomized Clinical Trial.
Sarwal, Rakesh; Dhamija, Rajinder K; Jain, Khushbu; Basavaraddi, Ishwar V.
  • Sarwal R; National Institution for Transforming India (NITI) Aayog, New Delhi.
  • Dhamija RK; Professor & Head of Neurology, Lady Hardinge Medical College, New Delhi.
  • Jain K; Assistant Professor of Biochemistry, Morarji Desai National Institute of Yoga, New Delhi.
  • Basavaraddi IV; Morarji Desai National Institute of Yoga, New Delhi.
J Ayurveda Integr Med ; : 100586, 2022 May 06.
Article in English | MEDLINE | ID: covidwho-2279899
ABSTRACT

Background:

The global outbreak of COVID-19 has created a challenging situation, especially for the frontline Health Care Professionals (HCPs), who are routinely exposed and thus are at a higher risk of infection. Pranayama, a component of Yoga, is known to improve immune function and reduce infection. However, no clinical trial on the efficacy of Pranayama in preventing COVID-19 has yet been conducted. Aim &

Objective:

This quasi-randomized clinical trial assessed the efficacy of Pranayama in preventing COVID-19 infection in HCPs routinely exposed to COVID-19.

Methodology:

The study was conducted at 5 different COVID-19 hospitals, India in year 2020. The inclusion criteria were being an HCP exposed to COVID-19 patients and being negative on antibody tests. 280 HCPs were recruited sequential and assigned to intervention and control groups. Of these, 250 HCPs completed the study. The intervention was twice daily practice, for 28 days, of specially designed Pranayama modules under the online supervision of Yoga instructors. The HCPs in the control group were advised to continue their normal daily routine, but no pranayama sessions. Participants who developed symptoms suggestive of COVID-19 were subjected to Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) or Point of Care Rapid Antigen Test (RAT) for confirmation of the diagnosis. All the participants were tested for antibodies to COVID-19 on 28th day of the intervention to detect any asymptomatic infection.

Results:

The intervention (123) and control (127) groups had comparable demographics and baseline characteristics. At end of 28 days of intervention, nine participants in the control group and one in the intervention group developed COVID-19 (P-value 0.01, Odds Ratio 0.107, 95% CI 0.86; Risk Ratio 0.11, 95% CI 0.89).

Conclusion:

The intervention of twice daily practice of the Pranayama module for 28 days in HCPs might have made a noteworthy contribution and may have helped in preventing COVID-19 infection. CTRI Number CTRI/2020/07/026667.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Traditional medicine Language: English Journal: J Ayurveda Integr Med Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Traditional medicine Language: English Journal: J Ayurveda Integr Med Year: 2022 Document Type: Article